Clinical trials in Terneuzen

Innovative research focusing on chronic lymphocytic leukemia and multiple myeloma treatments, evaluating novel therapeutic combinations and maintenance strategies.

• Targeted therapy combinations
• Maintenance treatment optimization
• Minimal residual disease monitoring

Studies explore the effectiveness of various drug combinations including venetoclax, obinutuzumab, and ibrutinib.

Advanced studies in HER2-positive and hormone receptor-positive breast cancer, investigating innovative treatment approaches and therapy optimization.

• Image-guided chemotherapy de-escalation
• Endocrine therapy combinations
• Treatment sequencing strategies

Trials focus on personalized treatment approaches and management of therapy-related symptoms.

Comprehensive research on migraine prevention in both adult and pediatric populations, evaluating new therapeutic options.

• Pediatric migraine treatment
• Long-term safety studies
• Prevention strategies

Clinical trials assess the safety and efficacy of atogepant across different age groups.

Studies addressing metastatic colorectal cancer treatment optimization, particularly focusing on elderly patient populations.

• Dose optimization studies
• Chemotherapy effectiveness
• Post-surgical treatment strategies

Research includes innovative approaches to chemotherapy dosing and aspirin as preventive therapy.